PharmEasy
MAINBOARD
Min. Investment
Issue size
₹0 Cr
GMP
Locked
Current subscription status: --
Expert verdict
Subscription (as on 04 August 2026, 06:30 PM)
Overall-
Qualified institutional buyers
Non-Institutional Buyers
Retail Investors
Employee
About company
- PharmEasy is a consumer healthcare “super app” that provides consumers with on-demand, home delivered access to a wide range of prescription, OTC pharmaceuticals.
Issue Details & Objective
Face value
₹1 per share
FAQs
Our SEBI-registered investment advisors give out verdicts for each IPO. You can refer to their expert verdict at the top of this page. Please note that these verdicts are for informational purposes only and should not be construed as investment advice. Markets are subject to risk, and investors should exercise their own discretion and diligence.
The issue size of PharmEasy IPO is ₹0 Cr
The PharmEasy IPO will be open for applications from null to null
The lot size of PharmEasy IPO is null and its minimum investment amount is null.
Grey market premium (GMP) is a premium amount at which grey market IPO shares are traded before they get listed in the stock exchange. The GMP for PharmEasy IPO is null
